Global X HealthTech ETF (NASDAQ:HEAL) Sees Large Growth in Short Interest

Global X HealthTech ETF (NASDAQ:HEAL) was the recipient of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 15,534 shares, a growth of 103.9% from the July 30th total of 7,620 shares. Based on an average daily volume of 6,569 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.5% of the company’s shares are short sold.

Global X HealthTech ETF Stock Performance

Shares of Global X HealthTech ETF stock opened at $29.72 on Friday. Global X HealthTech ETF has a 52-week low of $23.00 and a 52-week high of $33.59. The stock has a market capitalization of $31.50 million, a price-to-earnings ratio of 42.80 and a beta of 1.10. The company’s 50 day moving average price is $28.22 and its 200-day moving average price is $26.30.

Institutional Investors Weigh In On Global X HealthTech ETF

Institutional investors have recently added to or reduced their stakes in the company. Daiwa Securities Group Inc. bought a new stake in Global X HealthTech ETF in the 3rd quarter worth $11,239,000. WT Wealth Management increased its position in shares of Global X HealthTech ETF by 14.7% in the first quarter. WT Wealth Management now owns 101,116 shares of the company’s stock valued at $2,409,000 after acquiring an additional 12,945 shares during the period. Flow Traders U.S. LLC purchased a new position in shares of Global X HealthTech ETF in the third quarter valued at about $368,000. Raymond James Financial Inc. bought a new position in shares of Global X HealthTech ETF during the third quarter valued at about $274,000. Finally, Citadel Advisors LLC bought a new position in shares of Global X HealthTech ETF during the third quarter valued at about $216,000.

About Global X HealthTech ETF

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.